BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 24273168)

  • 1. A functional, genome-wide evaluation of liposensitive yeast identifies the "ARE2 required for viability" (ARV1) gene product as a major component of eukaryotic fatty acid resistance.
    Ruggles KV; Garbarino J; Liu Y; Moon J; Schneider K; Henneberry A; Billheimer J; Millar JS; Marchadier D; Valasek MA; Joblin-Mills A; Gulati S; Munkacsi AB; Repa JJ; Rader D; Sturley SL
    J Biol Chem; 2014 Feb; 289(7):4417-31. PubMed ID: 24273168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complementation analysis reveals a potential role of human ARV1 in GPI anchor biosynthesis.
    Ikeda A; Kajiwara K; Iwamoto K; Makino A; Kobayashi T; Mizuta K; Funato K
    Yeast; 2016 Feb; 33(2):37-42. PubMed ID: 26460143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sterol and diacylglycerol acyltransferase deficiency triggers fatty acid-mediated cell death.
    Garbarino J; Padamsee M; Wilcox L; Oelkers PM; D'Ambrosio D; Ruggles KV; Ramsey N; Jabado O; Turkish A; Sturley SL
    J Biol Chem; 2009 Nov; 284(45):30994-1005. PubMed ID: 19690167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia-inducible lipid droplet-associated induces DGAT1 and promotes lipid storage in hepatocytes.
    de la Rosa Rodriguez MA; Deng L; Gemmink A; van Weeghel M; Aoun ML; Warnecke C; Singh R; Borst JW; Kersten S
    Mol Metab; 2021 May; 47():101168. PubMed ID: 33465519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of subcellular lipid transport due to ARV1 deficiency disrupts organelle homeostasis and activates the unfolded protein response.
    Shechtman CF; Henneberry AL; Seimon TA; Tinkelenberg AH; Wilcox LJ; Lee E; Fazlollahi M; Munkacsi AB; Bussemaker HJ; Tabas I; Sturley SL
    J Biol Chem; 2011 Apr; 286(14):11951-9. PubMed ID: 21266578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of PPAR alpha for the effects of growth hormone on hepatic lipid and lipoprotein metabolism.
    Ljungberg A; Lindén D; Améen C; Bergström G; Oscarsson J
    Growth Horm IGF Res; 2007 Apr; 17(2):154-64. PubMed ID: 17307376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Yeast cells lacking the ARV1 gene harbor defects in sphingolipid metabolism. Complementation by human ARV1.
    Swain E; Stukey J; McDonough V; Germann M; Liu Y; Sturley SL; Nickels JT
    J Biol Chem; 2002 Sep; 277(39):36152-60. PubMed ID: 12145310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mice lacking
    Gallo-Ebert C; Francisco J; Liu HY; Draper R; Modi K; Hayward MD; Jones BK; Buiakova O; McDonough V; Nickels JT
    J Biol Chem; 2018 Apr; 293(16):5956-5974. PubMed ID: 29491146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased expression of ARV1 results in cholesterol retention in the endoplasmic reticulum and abnormal bile acid metabolism.
    Tong F; Billheimer J; Shechtman CF; Liu Y; Crooke R; Graham M; Cohen DE; Sturley SL; Rader DJ
    J Biol Chem; 2010 Oct; 285(44):33632-41. PubMed ID: 20663892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DGA1 (diacylglycerol acyltransferase gene) overexpression and leucine biosynthesis significantly increase lipid accumulation in the Deltasnf2 disruptant of Saccharomyces cerevisiae.
    Kamisaka Y; Tomita N; Kimura K; Kainou K; Uemura H
    Biochem J; 2007 Nov; 408(1):61-8. PubMed ID: 17688423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CDKN2A/p16INK4a suppresses hepatic fatty acid oxidation through the AMPKα2-SIRT1-PPARα signaling pathway.
    Deleye Y; Cotte AK; Hannou SA; Hennuyer N; Bernard L; Derudas B; Caron S; Legry V; Vallez E; Dorchies E; Martin N; Lancel S; Annicotte JS; Bantubungi K; Pourtier A; Raverdy V; Pattou F; Lefebvre P; Abbadie C; Staels B; Haas JT; Paumelle R
    J Biol Chem; 2020 Dec; 295(50):17310-17322. PubMed ID: 33037071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cold-sensitive phenotypes of a yeast null mutant of ARV1 support its role as a GPI flippase.
    Okai H; Ikema R; Nakamura H; Kato M; Araki M; Mizuno A; Ikeda A; Renbaum P; Segel R; Funato K
    FEBS Lett; 2020 Aug; 594(15):2431-2439. PubMed ID: 32449190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compound K modulates fatty acid-induced lipid droplet formation and expression of proteins involved in lipid metabolism in hepatocytes.
    Kim MS; Lee KT; Iseli TJ; Hoy AJ; George J; Grewal T; Roufogalis BD
    Liver Int; 2013 Nov; 33(10):1583-93. PubMed ID: 23998390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia-inducible lipid droplet-associated (HILPDA) is a novel peroxisome proliferator-activated receptor (PPAR) target involved in hepatic triglyceride secretion.
    Mattijssen F; Georgiadi A; Andasarie T; Szalowska E; Zota A; Krones-Herzig A; Heier C; Ratman D; De Bosscher K; Qi L; Zechner R; Herzig S; Kersten S
    J Biol Chem; 2014 Jul; 289(28):19279-93. PubMed ID: 24876382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Erg11 lanosterol 14-α-demethylase-Arv1 complex is required for Candida albicans virulence.
    Villasmil ML; Barbosa AD; Cunningham JL; Siniossoglou S; Nickels JT
    PLoS One; 2020; 15(7):e0235746. PubMed ID: 32678853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic role of ursolic acid on ameliorating hepatic steatosis and improving metabolic disorders in high-fat diet-induced non-alcoholic fatty liver disease rats.
    Li S; Liao X; Meng F; Wang Y; Sun Z; Guo F; Li X; Meng M; Li Y; Sun C
    PLoS One; 2014; 9(1):e86724. PubMed ID: 24489777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arv1 regulates PM and ER membrane structure and homeostasis but is dispensable for intracellular sterol transport.
    Georgiev AG; Johansen J; Ramanathan VD; Sere YY; Beh CT; Menon AK
    Traffic; 2013 Aug; 14(8):912-21. PubMed ID: 23668914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rescue of cardiomyopathy in peroxisome proliferator-activated receptor-alpha transgenic mice by deletion of lipoprotein lipase identifies sources of cardiac lipids and peroxisome proliferator-activated receptor-alpha activators.
    Duncan JG; Bharadwaj KG; Fong JL; Mitra R; Sambandam N; Courtois MR; Lavine KJ; Goldberg IJ; Kelly DP
    Circulation; 2010 Jan; 121(3):426-35. PubMed ID: 20065164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD36 and DGAT2 facilitate the lipid-lowering effect of chitooligosaccharides
    Shen X; Liang X; Ji X; You J; Zhuang X; Song Y; Yin H; Zhao M; Zhao L
    Food Funct; 2021 Sep; 12(18):8681-8693. PubMed ID: 34351342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urokinase-type plasminogen activator (uPA) stimulates triglyceride synthesis in Huh7 hepatoma cells via p38-dependent upregulation of DGAT2.
    Paland N; Gamliel-Lazarovich A; Coleman R; Fuhrman B
    Atherosclerosis; 2014 Nov; 237(1):200-7. PubMed ID: 25244504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.